News and Trends 23 Apr 2016BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community… April 23, 2016 - 4 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 22 Apr 2016UK Cannabis Biotech gets another Orphan Drug Designation by the FDA Cambridge based GW Pharmaceuticals has now been granted Orphan Drug Designation from FDA for Cannabidiol drug to treat a 3rd rare genetic… April 22, 2016 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 18 Apr 2016ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy While on a stop in New York, I had a chance to chat with Bernard Gilly, the founder and CEO… April 18, 2016 - 6 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 16 Apr 2016First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis! We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase… April 16, 2016 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2016It’s World Parkinson’s Disease Day! #EndParkinsons Today (April 11th) is the birthday of the memorable Dr James Parkinson, who discovered this major neurodegenerative disease. So what… April 11, 2016 - 4 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2016French Biotech gets €34M to bring Multiple Sclerosis Drug to the US MedDay (France) has raised €34M that should help pay a US phase III for its leading candidate for Multiple Sclerosis - as… April 11, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 7 Apr 2016Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech Heptares Therapeutics is licensing its portfolio of novel candidates for neurological diseases, including one for Alzheimer's, to Allergan for up to… April 7, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2016Leading German Biotech recruits New talent for Fight against Alzheimer’s Probiodrug (Germany) has hired Mark Booth as Chief Business Officer to propel this Pharma's global strategy. Among other important roles,… March 24, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 17 Mar 2016A Relief for Migraines at last? The Biotech race for the Ultimate Cure A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide… March 17, 2016 - 4 minutesmins - By Ekaterina Perets Share WhatsApp Twitter Linkedin Email
News and Trends 3 Mar 2016Reviewing Autism: Can Biotech open up New Horizons? While Autism Spectrum Disorders (ASD) affect approximately one in 68 children, this hasn't provoked much enthusiasm among pharmaceutical companies to… March 3, 2016 - 6 minutesmins - By Ekaterina Perets Share WhatsApp Twitter Linkedin Email
News and Trends 11 Feb 2016Sanofi-Genzyme: Still successful 5 years after the acquisition? Back in 2011, France's biggest Pharmaceutical company Sanofi decided to purchase Genzyme Corp. for more than $20 billion, thus becoming… February 11, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2016Finland, France and Harvard Bioprint Brains to Understand the 3D Structure Researchers at Harvard University in collaboration with French and Finnish academic institutions have managed to 3D-bioprint a brain with the distinctive… February 4, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jan 2016Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease What updates have occurred in the Neurodegenerative disease field as of late? New appointments by the Dementia Discovery Fund, which… January 25, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jan 2016Groningen’s MedTech Hub for Neurosurgery is Actually a Biotech Hotspot I visited Groningen (Netherlands) and the University Medical centre there in November, and it was interesting to note the tight knit… January 22, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2016Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists Founded in just 2013 by German Proteros and the US Atlas Ventures, Rodin Therapeutics is working epigenetics into discovery of… January 8, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jan 2016Growing Mini-Brains in Labs to Better Understand Neurological Disease Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological… January 6, 2016 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 22 Dec 2015Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing Mimetas from Leiden (NL) has now been financed to develop an Organ-on-Chip (tissue model) to specifically test Neurotoxicity, as a… December 22, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2015Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials Probiodrug's phase I tolerability and efficacy trial for Alzheimer's didn't quite go as planned, although results are in and it… December 15, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2015Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons Relatives of the Jellyfish, researchers at the University of Geneva (Switzerland) have now proven the regenerative abilities of Hydra involved… December 7, 2015 - 3 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2015Black Friday Ruin as TWO Biotechs Fail in Phase III Trials A shocking Black Friday for these two Biotechs: Both CytoTools (Germany) and MedDay (France) phase III trials in chronic disease… December 4, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email